Prevalence and prognostic impact of hepatopulmonary syndrome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective cohort study

BACKGROUND: To determine the prevalence and prognostic impact of hepatopulmonary syndrome (HPS) in patients with unresectable hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE). METHODS: Fifty-four patients with unresectable HCC undergoing TACE between December 2014 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, He, Tsauo, Jiaywei, Zhang, Xiaowu, Ma, Huaiyuan, Weng, Ningna, Yang, Zhengqiang, Li, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746741/
https://www.ncbi.nlm.nih.gov/pubmed/36255217
http://dx.doi.org/10.1097/CM9.0000000000002034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746741/
https://www.ncbi.nlm.nih.gov/pubmed/36255217
http://dx.doi.org/10.1097/CM9.0000000000002034

Ejemplares similares